Using a biofilm model, infections by Staphylococcus aureus, coagulase-negative staphylococci and enterococci were studied. The biofilms were exposed to quinupristin/dalfopristin and five comparator antibiotics: ciprofloxacin, vancomycin, teicoplanin, flucloxacillin and erythromycin. Two methods of exposure to the drugs were used: constant for 1 h, and exponentially decreasing, with the rate of dilution being matched to the half-lives of the antibiotics. The effects of antibiotic exposure were monitored by performing viable counts on the cells eluted from the biofilms. The results are presented as the inhibitory or bactericidal effect (the reduction in numbers of bacteria eluted from the biofilms) and recovery times (the time taken for the number of cells eluted from the biofilms to return to the number eluted before the drug exposure). Quinupristin/dalfopristin was the most effective of the six antibiotics studied, especially against enterococci. However, there were no significant differences in the effects, inhibitory/ bactericidal or recovery times, produced by the two methods of exposure. The two glycopeptides showed a surprising lack of activity.
Introduction
The incidence of multidrug-resistant Gram-positive infections is increasing, perhaps partly because drug development in the last 20 years has concentrated largely on agents active against Gram-negative pathogens. 1 Quinupristin/ dalfopristin (Synercid) is a semisynthetic parenterally administered streptogramin antibiotic. It consists of a mixture of quinupristin (30%) and dalfopristin (70%). These two compounds act synergistically by binding to bacterial ribosomes and inhibiting protein synthesis. Quinupristin/dalfopristin is active against Gram-positive bacteria including vancomycin-resistant enterococci (VRE) 2, 3 and methicillin-resistant Staphylococcus aureus (MRSA). 3, 4 Biofilm-associated disease in humans is widespread and increasing, and occurs largely as a consequence of the increase in the use of indwelling medical devices, for example catheters and prosthetic devices. 5 Biofilm cells typically have very slow growth rates and are under some sort of nutrient limitation, whereas cells grown in batch cultures in vitro are usually in nutrient-rich laboratory medium. Consequently the physiology of the two populations will differ greatly. Adherent biofilms persist in spite of active host immune defence systems and antimicrobial chemotherapy.
5-8 For these reasons we have studied inhibitory/ bactericidal activity and recovery times of selected Grampositive pathogens in a biofilm model using quinuprisitn/ dalfopristin and five comparator antibiotics. In clinical situations when intermittent antibiotic dosing is used, the organisms are subjected to decreasing concentrations of the drug, so experimental exposure of bacteria in vitro to constant levels of antibiotics does not reflect the true clinical situation. 9 To compare in vitro activity and to simulate the situation in vivo, bacteria were exposed to a constant concentration of the drugs for 1 h and, using an in vitro pharmacokinetic model, to exponentially decreasing concentrations.
Materials and methods
Three S. aureus strains were used: ATCC 29213, an MRSA S. aureus 261 and a strain inducibly resistant to erythromycin S. aureus (IRE). Two isolates of coagulase-
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MIC and MBC determinations
MICs and MBCs were determined using the standard broth dilution method 10 and Mueller-Hinton broth (Oxoid, Basingstoke, UK).
Biofilm studies
The biofilm model used in this study was a modification of the Sorbarod model, 11 in which quarter Sorbarods were used to reduce the number of bacteria forming the biofilms. A Sorbarod (Ilacon Ltd, Kent, UK) consists of a cylindrical paper sleeve encasing a compacted concertina of cellulose fibres. Cells attach to the cellulose fibre plug and are subsequently perfused with medium (Mueller-Hinton broth) from one side; cells are shed from the opposite side. After initial loss of loosely attached cells into the eluted medium, a steady state is achieved where the adherent biomass and the rate of cell release from the membrane remain constant. The number of cells eluted from the biofilm reflects the number of actively dividing cells in the biofilm, and so it can be be used to quantify the effects of antibiotics on the biofilm cells.
Exposure to constant antibiotic concentrations for 1 h
Test and control biofilms were set up and perfused with Mueller-Hinton broth. When the biofilms reached a steady state, i.e. when a constant number of cells were being eluted from them (as determined by performing viable counts on the eluate), the test biofilms were perfused for 1 h with Mueller-Hinton broth containing the appropriate concentration of antibiotic. The concentrations used were the MIC and MBC for the bacteria being tested. After this exposure, perfusion continued in the absence of the drug. The flow rate of the medium (and antibiotic) was 15 mL/h throughout all experiments. Viable counts were performed on the eluted cells at hourly intervals, 2 h before exposure, during exposure and up to 7 h after exposure to the antibiotics. The viable counts of bacteria were determined by spiral plating (Spiral Systems, Cincinnatti, OH, USA) of serially diluted samples of eluate on nutrient agar (Oxoid).
Exposure to exponentially decreasing concentrations of antibiotics
Perfusing biofilms with media via a dilution vessel into which drugs are added allows biofilm cells to be exposed to exponentially decreasing concentrations of antibiotic. This method of perfusion is achieved by using an uninoculated flask as a dilution vessel for the antibiotic (see Figure 1 ). Biofilms were established as described above, except that the tubing carrying the medium from the medium reservoir to the biofilms went via the dilution vessel. Once the biofilms reached a steady state, the antibiotic was added directly to the dilution vessel. The biofilm cells were, thus, exposed to an exponentially decreasing concentration of the drug. The dilution rate of the antibiotics was matched to their half-lives and the volume of medium in the dilution vessel was calculated from the equation t 1/2 ϭ 0.6931 V/r, based on first-order decay kinetics (see Appendix). The half-lives of the antibiotics used in these experiments are as follows: quinupristin/dalfopristin, 1.36 h; ciprofloxacin, 3.5 h; vancomycin, 8.0 h; teicoplanin, 50 h; flucloxacillin, 1.0 h; and erythromycin, 1.25 h. The flow rate remained at 15 mL/h throughout all experiments. Viable counts were performed on the cells eluted from the biofilms before and during perfusion with the antibiotics, as described above for the constant drug concentration exposure. All experiments were performed in triplicate. 
Results
The MICs and MBCs for test strains are given in Table I . The inhibitory/bactericidal effects of the antibiotics and the recovery times following exposure to constant concentrations for 1 h are given in Tables II and III and for exposure   to exponentially decreasing concentrations in Tables IV  and V . Overall there was no significant difference in the effects, inhibitory/bactericidal and recovery times, seen with these two methods of exposure. Quinupristin/dalfopristin appeared to be the most effective of the six antibiotics, especially against the enterococci. The poor activity 
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Discussion
The majority of the MICs and MBCs obtained for quinupristin/dalfopristin were in agreement with those described previously, 4,12-17 but for one of the S. aureus strains tested, (261), the MBC of quinupristin/dalfopristin was at least four times higher than the MIC, indicating in vitro phenotypic tolerance. 18, 19 Such raised MBCs could be of concern both clinically and technically as there is no way to predict which strains will behave in this way. Some constitutive macrolide, lincosamide and streptogramin B (MLS B )-resistant S. aureus strains have raised MBCs of quinupristin/ dalfopristin. 20 It has been suggested that treatment with quinupristin/dalfopristin of serious infections such as endocarditis, caused by MLS B -resistant S. aureus, might only be successful where strains have a low MBC for quinupristin/dalfopristin. 21 The lack of any significant difference between the effects of the antibiotics, inhibitory or bactericidal and recovery times following both methods of exposure, was unexpected. Owing to the method of perfusion, the concentrations of the drugs in the bacterial biofilms in the exponentially decreasing model were reduced only by dilution at the rate of the half-lives of the antibiotics. The recovery times of the bacterial biofilms in the presence of decreasing antibiotic concentrations were therefore compared with recovery times for the 1 h constant concentration model which were in the absence of any drugs. The bacteria in the exponentially decreasing concentration model would have been exposed to subinhibitory concentrations of the antibiotics. Subinhibitory concentrations of antimicrobial agents, including those used in this study, [22] [23] [24] [25] often influence the growth rate of bacteria, especially after exposure to suprainhibitory levels of the drug. Thus bacteria exposed to decreasing concentrations of antibiotics would, therefore, have been expected to take longer to recover than those exposed to constant concentrations. Although the recovery times for the two methods of exposure were not significantly different, the times for exponentially decreasing exposure, especially to ciprofloxacin, are slightly longer than those for the constant concentration exposure. For several organism-antibiotic combinations, no recovery was seen within the 420 min of monitoring and further differences may have been apparent if recovery had been followed for longer.
Given the increase in biofilm-associated infections, it is important to study how antimicrobial agents affect biofilms in vitro. In vitro determination of MICs and post-antibiotic 26 When a biofilm is at steady state, cells are shed from it at a constant rate, which could be considered as the 'normal' rate. The number of cells shed from a biofilm will decrease when the biofilm is exposed to an inhibitory concentration of a drug, and will increase on removal of the drug, eventually returning to the original steady state. Thus the recovery time of the biofilms could be considered as representing a return to normal growth as with the batch culture PAE.
In a similar study using a different biofilm model, the Swinnex model, which uses a much denser filter matrix, we previously investigated the effects of ciprofloxacin on Escherichia coli (S. Gander and P. Gilbert, unpublished). The effects of exposure to constant and exponentially decreasing concentrations of the antibiotic were investigated. Although the inhibitory/bactericidal effects were similar for both methods of exposure, cells exposed to a decreasing concentration of ciprofloxacin took longer to recover (24 h) than cells exposed to a constant concentration (20 h).
The two methods of exposure used in our study, constant for 1 h and exponentially decreasing, could be seen as analogous to administering antibiotics by infusion and parenteral dosing. If this were the case, the results of this study would suggest that there are no significant differences between these two methods of dosing. Rybak et al. 27 performed a similar study, looking at the effects of quinupristin/dalfopristin administered by continuous infusion and parenterally, using S. aureus-infected fibrin-platelet clots in an in vitro infection model. They also found no significant differences between the bactericidal effects produced by the two dosing regimens.
Other studies have investigated the effect of quinupristin/dalfopristin on adherent bacteria. Hamilton-Miller & Shah 28 investigated the effects of quinupristin/dalfopristin and ciprofloxacin on Staphylococcus epidermidis biofilms. They found that both the antibiotics had the same bactericidal effects on the biofilms. Although they used much higher concentrations than we did, the results are in agreement. Berthaud & Desnottes 29 looked at the effect of quinupristin/dalfopristin and vancomycin on S. aureus biofilms cultured on fibronectin-coated nylon membrane discs. They found that at 5, 10 and 50 ϫ MIC, the two antibiotics had a similar bactericidal effect. These results do not agree with those of this study, probably because of the higher concentrations of antibiotics used. Our investigations indicate that quinupristin/dalfopristin would be effective for treating Gram-positive infections, including those caused by multidrug-resistant MRSA and VRE. 
